Overall, these results indicate that targeting MSLN can significantly enhance the infiltration of induced neoantigen specific T cells, thereby enhancing its anti‐tumor efficacy in pancreatic cancer. The gene discussed is MSLN; the disease is familial pancreatic carcinoma.